Introduction SLE is a chronic autoimmune disease characterised by multisystem involvement and fluctuating clinical course, ...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq® ...